USPTO serial 90855395
HYCOR IMPROVING LIVES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 13, 2022
- Examiner
- NEHMER, JASON ROBERT
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HYCOR IMPROVING LIVES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gregory B. Coy
Gregory B. Coy TAFT STETTINIUS & HOLLISTER LLP1 INDIANA SQUARE, SUITE 3500INDIANAPOLIS, IN 46204UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents and preparations for scientific, clinical laboratory, medical laboratory, reference laboratory, hospital laboratory, physician office laboratory, companion diagnostic or research use, except for medical or veterinary use; Quality control and calibrating fluids and reagents for medical diagnostic instruments; control and calibrating fluids and reagents for laboratory instruments used for in vitro diagnostic testing and/or analysis; diagnostic reagents for scientific or medical research use, except for medical or veterinary use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; reagents for use in scientific apparatus for chemical or biological analysis; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in body fluids, cell and tissue analysis for in vitro diagnostic use; diagnostic test kits comprised of monoclonal antibodies, antigens, buffers, assay components and reagents for scientific or medical laboratory use; assays for research purposes; assay kits consisting primarily of assays, pre-mixes and onboard mixes for scientific, clinical laboratory, reference laboratory, hospital laboratory, physician office laboratory, companion diagnostic or research purposes | ACTIVE | — |
| 005 | Medical diagnostic reagents; biological reagents and chemical preparations and reagents for medical purposes; medical diagnostic assays for testing of bodily fluids in the detection, monitoring, and/or prediction of disease or other conditions, disease states and/or clinical response; containers and kits containing medical diagnostic reagents for use in blood analyzers and analyzers for measuring, testing and analyzing body fluids; diagnostic preparations for medical purposes; diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics, namely, for the testing of body fluids for use in disease detection, namely, autoimmune disease, allergic hypersensitivity and allergy disease; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; autoimmune diagnostic test kits consisting primarily of reagents, buffer concentrates, calibrators, controls, substrates, diluents, capture reagents, mixes of capture reagents, antibodies and conjugates for medical use for testing presence of autoimmune disease and allergic hypersensitivity; Quantitative Specific Immunoglobulin E (IgE) test kits consisting primarily of antibodies, capture reagents, mixes of capture reagents, calibrators, calibration verification samples, controls and reagents for testing presence of allergic hypersensitivity and allergy disease; diagnostic reagents for medical use; assay kits consisting primarily of assays for medical use for testing presence of allergic hypersensitivity and allergy disease | ACTIVE | — |
| 009 | Research and commercial laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or level of autoimmune disease or allergic hypersensitivity; laboratory instruments for in vitro diagnostic testing and/or analysis of body fluid samples; laboratory equipment for use in the field of medical diagnostics, namely, laboratory test and collection kits comprised of magnetic microparticles, ready-to-use immunochemistry reagents and stock fluids for in vitro diagnostic testing of blood or other body fluid to detect the presence of autoimmune disease, allergic hypersensitivity or allergy disease; calibration devices for calibrating blood analyzers; analyzers for measuring, testing and analyzing body fluids; laboratory instruments for allergic hypersensitivity, allergy disease and autoimmune disease diagnostics and identification; laboratory apparatus, namely, a diagnostic instrument utilizing microparticle-based solid phase and chemiluminescent/fluorescent detection together with related reagents for medical use; downloadable computer operating software, firmware and hardware for medical diagnostic instruments; downloadable computer operating software, firmware and hardware for immunoassay analyzers for blood and other bodily fluid testing; downloadable computer software, firmware and hardware for configuring, supporting, monitoring and troubleshooting medical diagnostic instruments; downloadable computer software, firmware and hardware for configuring, supporting, monitoring and troubleshooting immunoassay analyzers for blood and/or bodily fluid testing; electronic data interface, namely, keyboards and LIS interfaces for medical diagnostic instruments; electronic data interface, namely, computers, keyboards and LIS interfaces for immunoassay analyzers and blood and/or bodily fluid testing systems; downloadable computer software, firmware and hardware for managing interface between medical diagnostic instruments, laboratories and other systems; downloadable computer software, firmware and hardware for managing interface between laboratory instruments, laboratories and other systems; downloadable computer software, firmware and hardware for processing diagnostic laboratory data; downloadable computer software, firmware and hardware for use in medical diagnostic testing; downloadable computer software, firmware and hardware for analyzing allergic and autoimmune diseases; downloadable electronic publications, namely, instruction sheets and manuals for in vitro diagnostic instruments, laboratory automation systems recorded on computer-readable media, and related software | ACTIVE | — |
| 010 | Immunoassay analyzers for medical diagnostic use; medical diagnostic instruments for in vitro diagnostic testing and/or analysis; medical diagnostic instruments for the analysis of body fluids; medical equipment for testing bodily fluids for medical diagnosis; medical diagnostic analyzers for measuring, testing and analyzing blood or other body fluids; medical diagnostic apparatus, namely, automated enzyme immunoassay analyzer for allergic hypersensitivity and allergy disease, autoimmune disease diagnostic testing and companion diagnostic testing; medical immunoassays, diagnostic tests and kits used in blood or other body fluid testing for allergic hypersensitivity and allergy disease, autoimmune disease diagnostic testing and companion diagnostic testing comprised of magnetic microparticles, ready-to-use immunochemistry reagents and stock fluids; medical apparatus, namely, allergen kits for testing presence of allergic hypersensitivity and allergy disease comprised of magnetic microparticles, ready-to-use immunochemistry reagents and stock fluids for in vitro diagnostic testing of blood or other body fluid to detect the presence of allergic hypersensitivity or allergy disease; medical disposable cups, cuvettes, probe tips and tubes | ACTIVE | — |
| 037 | Maintenance and repair of medical diagnostic equipment; providing remote electronic troubleshooting services in the nature of maintenance and repair of medical diagnostic equipment for laboratories; providing installation, maintenance and repair services for medical diagnostic instruments; maintenance of computer hardware for blood and other body fluid testing instruments and system | ACTIVE | — |
| 041 | Providing an online computer database featuring non-downloadable publications in the nature of operating manuals for in vitro diagnostic laboratory instruments and related software | ACTIVE | — |
| 042 | Providing technical support services for in vitro diagnostic laboratory instruments and systems, namely, troubleshooting in the nature of diagnosing problems with the software, firmware and hardware in vitro diagnostic laboratory instruments; providing technological monitoring services for in vitro diagnostic laboratory equipment to evaluate proper functioning; remote monitoring of medical diagnostic laboratory systems to evaluate proper functioning; providing temporary use of non-downloadable, web-based software for management, tracking, reporting, sharing, monitoring and analysis of data pertaining to blood and other bodily fluid testing instruments and systems and pertaining to performance or errors associated with the instruments and systems and for managing data associated with the instruments and systems; application service provider, namely, hosting, managing, developing, and maintaining applications, software, and web sites related to medical diagnostics instruments and systems; hosting an on-line network environment for users to share data in the field of medical diagnostics; maintenance and updates of computer software and firmware for blood and other body fluid testing instruments and systems | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hycor Biomedical LLC
- Other trademarks owned by Hycor Biomedical LLC
- Other trademarks owned by Hycor Biomedical LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 037
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named HYCOR IMPROVING LIVES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 13, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 13, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 10, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 9, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 9, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Nov 9, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 25, 2022 | IUAF | USE AMENDMENT FILED | — |
| Oct 25, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 24, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 29, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 29, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 9, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 8, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 20, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 15, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 14, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 2, 2021 | NWAP | NEW APPLICATION ENTERED | — |